Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-24-044243
Filing Date
2024-04-15
Accepted
2024-04-15 09:10:50
Documents
6
Effectiveness Date
2024-04-15

Document Format Files

Seq Description Document Type Size
1 S-8 ubx-s8-20240415.htm S-8 144148
2 EX-5.1 ubx-ex5_1.htm EX-5.1 30390
3 EX-23.1 ubx-ex23_1.htm EX-23.1 3068
4 EX-FILING FEES ubx-exfiling_fees.htm EX-FILING FEES 31544
5 GRAPHIC img152857925_0.jpg GRAPHIC 58631
6 GRAPHIC img152857925_1.jpg GRAPHIC 58366
  Complete submission text file 0000950170-24-044243.txt   371746
Mailing Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 416-1192
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

EIN.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-278679 | Film No.: 24843275
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)